Physician
Infectious Disease
Dr. Thomas C. Greenough, MD
|
|
Give Review
Thomas Greenough is an expert in the field of Infectious Disease. He went to University of Rochester School of Medicine and Dentistry. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Thomas C. Greenough, MD is a published doctor. He has 45 publications published. The most current publication "Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection.
- Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.
- A novel assay for ADCC against HIV-1 or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.
- Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.
- CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cells.
- On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.
- Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syri...
- Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus.
- Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation.
- Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunopro...
- Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.
- Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.
- Alterations in HIV-1 LTR promoter activity during AIDS progression.
- Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human ...
- Enhanced culture method for detection of replication-competent virus in peripheral blood mononuclear cells of HIV type 1-infected individuals.
- Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
- Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.
- Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus.
- Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
- Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS.
- Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans.
- Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir.
- Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.
- Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with ...
- CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid t...
- Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
- Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence.
- Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.
- Partial "repair" of defective NEF genes in a long-term nonprogressor with human immunodeficiency virus type 1 infection.
- Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.
- Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.
- Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1.
- Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series.
- In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels ...
- Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.
- Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression.
- High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.
- Bartonella henselae endocarditis in an immunocompetent adult.
- Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection.
- Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.
- High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection.
- Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.
- Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy.
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Schools
University Of Rochester
University HospBoston University Med Center
University Mass Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Massachusetts -
Boston University Medical Center -
University of Rochester School of Medicine and Dentistry
Hospital
-
UMass Memorial Medical Center
Drug Facts
| NPI NUMBER | 1184607665 | |
| NPPES Provider LastName | GREENOUGH | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 016550002 | |
| NPPES Provider State | MA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 447.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 2.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184607665 |
| Last Name Of The Provider | GREENOUGH |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Daniel H. Libraty, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Neil R. Blacklow, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sonia N. Chimienti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence C. Madoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart M. Levitz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Douglas T. Golenbock, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark S. Klempner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Raul E. Davaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iris Partovi, MD |
|
|
Dr. Francis A. Ennis, MD
This Doctor is OpenDoctor Recommended.
|